ArticleClinical genitourinary cancer2024

A Panel-Based Mutational Signature of Mismatch Repair Deficiency is Associated With Durable Response to Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer.

Daniel Boiarsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.